Showing 1 to 12 of 28 results
Cervical Cancer Awareness: Don't Ignore Unusual Bleeding
A 50-year-old Pakistani woman, Saima Ali, shares her experience with early-stage cervical cancer, highlighting the importance of seeking medical attention for unusual vaginal bleeding or spotting between periods, especially in the context of perimenopause.
Cervical Cancer Awareness: Don't Ignore Unusual Bleeding
A 50-year-old Pakistani woman, Saima Ali, shares her experience with early-stage cervical cancer, highlighting the importance of seeking medical attention for unusual vaginal bleeding or spotting between periods, especially in the context of perimenopause.
Progress
36% Bias Score
China Approves First Domestic 9-Valent HPV Vaccine
China approved Cecolin 9, its first domestically developed 9-valent HPV vaccine, addressing a market previously dominated by foreign companies; this follows over 18 years of research and multiple clinical trials, and aims to reduce cervical cancer risk significantly by expanding vaccination access.
China Approves First Domestic 9-Valent HPV Vaccine
China approved Cecolin 9, its first domestically developed 9-valent HPV vaccine, addressing a market previously dominated by foreign companies; this follows over 18 years of research and multiple clinical trials, and aims to reduce cervical cancer risk significantly by expanding vaccination access.
Progress
44% Bias Score
FDA-Approved At-Home Cervical Cancer Test Aims to Increase Early Detection
A new at-home cervical cancer screening test, approved by the FDA, offers a convenient and less invasive alternative to traditional methods, potentially increasing early detection rates and reducing mortality in California, with plans for nationwide rollout.
FDA-Approved At-Home Cervical Cancer Test Aims to Increase Early Detection
A new at-home cervical cancer screening test, approved by the FDA, offers a convenient and less invasive alternative to traditional methods, potentially increasing early detection rates and reducing mortality in California, with plans for nationwide rollout.
Progress
60% Bias Score
FDA Approves At-Home Cervical Cancer Test
The FDA approved Teal Health's at-home cervical cancer test, the Teal Wand, a 96% accurate self-collection device designed to increase screening rates and potentially reduce the 4,000 annual U.S. deaths from cervical cancer by detecting HPV, the virus responsible for almost all cases.
FDA Approves At-Home Cervical Cancer Test
The FDA approved Teal Health's at-home cervical cancer test, the Teal Wand, a 96% accurate self-collection device designed to increase screening rates and potentially reduce the 4,000 annual U.S. deaths from cervical cancer by detecting HPV, the virus responsible for almost all cases.
Progress
36% Bias Score
Family Urges HPV Vaccination After Daughter's Death
The family of a 25-year-old woman who died from cervical cancer in 2012 due to HPV are urging parents to vaccinate their children after the virus was found to be responsible for her death. The HPV vaccine has been available in the UK since 2008 for girls and 2019 for boys.
Family Urges HPV Vaccination After Daughter's Death
The family of a 25-year-old woman who died from cervical cancer in 2012 due to HPV are urging parents to vaccinate their children after the virus was found to be responsible for her death. The HPV vaccine has been available in the UK since 2008 for girls and 2019 for boys.
Progress
48% Bias Score
India Trains 100,000 Doctors to Promote HPV Vaccine to Eliminate Cervical Cancer
India is training 100,000 doctors to promote the HPV vaccine to eliminate cervical cancer, which accounts for 20% of global cases, with the government expected to include it in its national vaccination program in 2024, addressing low uptake and misinformation.
India Trains 100,000 Doctors to Promote HPV Vaccine to Eliminate Cervical Cancer
India is training 100,000 doctors to promote the HPV vaccine to eliminate cervical cancer, which accounts for 20% of global cases, with the government expected to include it in its national vaccination program in 2024, addressing low uptake and misinformation.
Progress
40% Bias Score
England Extends Cervical Cancer Screening Interval to Five Years
Starting July, England will screen women aged 25-49 for cervical cancer every five years instead of three, impacting up to seven million people, based on UK National Screening Committee recommendations and studies showing similar cancer detection rates with less frequent testing.
England Extends Cervical Cancer Screening Interval to Five Years
Starting July, England will screen women aged 25-49 for cervical cancer every five years instead of three, impacting up to seven million people, based on UK National Screening Committee recommendations and studies showing similar cancer detection rates with less frequent testing.
Progress
36% Bias Score
Declining HPV Vaccination Rates Threaten England's Cervical Cancer Elimination Plan
A decline in HPV vaccination rates among children in England, falling 17 percentage points since the pandemic, threatens the country's plan to eliminate cervical cancer by 2040, as HPV causes 99 percent of cervical cancer cases. The decline is attributed to parents' hesitancy and "vaccine fatigue", ...
Declining HPV Vaccination Rates Threaten England's Cervical Cancer Elimination Plan
A decline in HPV vaccination rates among children in England, falling 17 percentage points since the pandemic, threatens the country's plan to eliminate cervical cancer by 2040, as HPV causes 99 percent of cervical cancer cases. The decline is attributed to parents' hesitancy and "vaccine fatigue", ...
Progress
40% Bias Score
HPV, Cervical Cancer Prevention, and Early Detection
Cervical cancer, primarily caused by HPV, is preventable through vaccination (recommended for ages 9-14), regular Pap tests and HPV tests (starting at age 21), and safe sex practices; early detection significantly improves treatment outcomes.
HPV, Cervical Cancer Prevention, and Early Detection
Cervical cancer, primarily caused by HPV, is preventable through vaccination (recommended for ages 9-14), regular Pap tests and HPV tests (starting at age 21), and safe sex practices; early detection significantly improves treatment outcomes.
Progress
16% Bias Score
FDA Approves First At-Home Cervical Cancer Screening Device
The FDA approved Teal Wand, an at-home self-collection device for cervical cancer screening, allowing women to collect samples at home and mail them for HPV testing using Roche's test, aiming to increase screening rates and improve outcomes.
FDA Approves First At-Home Cervical Cancer Screening Device
The FDA approved Teal Wand, an at-home self-collection device for cervical cancer screening, allowing women to collect samples at home and mail them for HPV testing using Roche's test, aiming to increase screening rates and improve outcomes.
Progress
36% Bias Score
Misreported Cervical Cancer Tests Lead to Woman's Death
Louise Gleadell, 38, died of cervical cancer in March 2018 due to two misreported negative cervical screening tests in 2008 and 2012 by University Hospitals of Leicester NHS Trust; an internal review revealed inadequate samples, yet Ms. Gleadell and her family were not informed, leading to a prevent...
Misreported Cervical Cancer Tests Lead to Woman's Death
Louise Gleadell, 38, died of cervical cancer in March 2018 due to two misreported negative cervical screening tests in 2008 and 2012 by University Hospitals of Leicester NHS Trust; an internal review revealed inadequate samples, yet Ms. Gleadell and her family were not informed, leading to a prevent...
Progress
44% Bias Score
HPV: Vaccines, Screenings, and the Fight for Cervical Cancer Elimination
Human Papillomavirus (HPV) infects over 80% globally; while effective vaccines and screenings exist, unequal access remains a challenge; Spain's vaccination coverage exceeds 92%, and the country is shifting to population-based screenings to improve equitable access and reduce cervical cancer inciden...
HPV: Vaccines, Screenings, and the Fight for Cervical Cancer Elimination
Human Papillomavirus (HPV) infects over 80% globally; while effective vaccines and screenings exist, unequal access remains a challenge; Spain's vaccination coverage exceeds 92%, and the country is shifting to population-based screenings to improve equitable access and reduce cervical cancer inciden...
Progress
12% Bias Score
Showing 1 to 12 of 28 results